Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1

Conditions

Pancreatic Neoplasms 3Neoplasms 2Sarcoidosis 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Pancreatic Diseases 1Pancreatic Cyst 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Lymphoma, Follicular 1Lymphoma 1Lymphadenopathy 1Lung Neoplasms 1Disease 1

Interventions

Rituximab 295Cyclophosphamide 240Peripheral Blood Stem Cell Transplantation 114fludarabine phosphate 110Filgrastim 93Etoposide 85Radiotherapy 81Lenalidomide 79Vincristine 78Prednisone 77Mycophenolic Acid 66Doxorubicin 61Cyclosporine 59Whole-Body Irradiation 58Bendamustine Hydrochloride 58Melphalan 57Tacrolimus 53Busulfan 51fludarabine 50Cytarabine 48obinutuzumab 46Methotrexate 45Antilymphocyte Serum 43Bortezomib 42Methylprednisolone 37Carmustine 37sargramostim 36ibritumomab tiuxetan 32ibrutinib 30Dexamethasone 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lymphoma, Follicular × Needles × Clear all
NCT01218243 2013-05-27

An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Phase 2 Completed
100 enrolled 14 charts
GenitourinaryLymphoid

Lymphoma, Follicular, Prostatic Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡